Cargando…
Binding of the angiogenic/senescence inducer CCN1/CYR61 to integrin α(6)β(1) drives endocrine resistance in breast cancer cells
CCN1/CYR61 promotes angiogenesis, tumor growth and chemoresistance by binding to its integrin receptor α(v)β(3) in endothelial and breast cancer (BC) cells. CCN1 controls also tissue regeneration by engaging its integrin receptor α(6)β(1) to induce fibroblast senescence. Here, we explored if the abi...
Autores principales: | Espinoza, Ingrid, Yang, Lin, Steen, Travis Vander, Vellon, Luciano, Cuyàs, Elisabet, Verdura, Sara, Lau, Lester, Menendez, Javier A., Lupu, Ruth |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8876916/ https://www.ncbi.nlm.nih.gov/pubmed/35148282 http://dx.doi.org/10.18632/aging.203882 |
Ejemplares similares
-
The metastasis inducer CCN1 (CYR61) activates the fatty acid synthase (FASN)-driven lipogenic phenotype in breast cancer cells
por: Menendez, Javier A., et al.
Publicado: (2016) -
Heregulin Drives Endocrine Resistance by Altering IL-8 Expression in ER-Positive Breast Cancer
por: Papadimitropoulou, Adriana, et al.
Publicado: (2020) -
Fatty Acid Synthase Is a Key Enabler for Endocrine Resistance in Heregulin-Overexpressing Luminal B-Like Breast Cancer
por: Menendez, Javier A., et al.
Publicado: (2020) -
The matrix protein CCN1 (CYR61) induces apoptosis in fibroblasts
por: Todorovicç, Viktor, et al.
Publicado: (2005) -
The Roles of CCN1/CYR61 in Pulmonary Diseases
por: Zhu, Yin, et al.
Publicado: (2020)